整体血栓激素生成显示了显著的低凝血状态,在患者的不补偿性肝硬化
Alberto Zanetto1, Elena Campello2, Cristiana Bulato3
1Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy. Electronic address: https://twitter.com/azanetto.
Journal of thrombosis and haemostasis : JTH
|October 22, 2023
概括
肝硬化患者的全血血生成 (TG) 显示出与血测试不同的情况. 虽然补偿性肝硬化显示TG增加,但不补偿性肝硬化表明低凝血状态,与血发现形成鲜明对比.
科学领域:
- 凝血科学是一门凝血科学.
- 血液学 血液学 血液学
- 肝脏疾病研究 肝脏疾病研究
背景情况:
- 肝硬化患者通常在血小板贫乏血 (PPP) 中表现出正常到增加的血小板生成 (TG).
- 全血 (WB) TG通过包括所有血细胞提供了更有生理学的评估.
研究的目的:
- 在肝硬化患者中,将全血TG (WB-TG) 与血小板贫血血TG (PPP-TG) 相比较.
- 通过使用先进的TG测定,研究肝硬化不同阶段的凝血状况.
主要方法:
- 凝血评估包括常规检测,XIII因子,天然抗凝剂,PPP-TG和WB-TG.
- 用和没有血栓模块素进行了TG测定.
- 研究了108名肝硬化患者 (Child-Pugh A/B/C) 和25名健康对照.
主要成果:
- 在PPP-TG和WB-TG中,补偿性肝硬化显示TG容量增加 (更高的内源性血栓激素潜力-ETP).
- 脱补偿性肝硬化通过PPP-TG显示出高凝性,但通过WB-TG显示出显著的低凝性 (延长滞后时间,减少ETP).
- 在缺乏补偿的患者中,感染和贫血恶化了TG容量.
结论:
- 补偿性肝硬化与增强的TG容量有关.
- 在非补偿性肝硬化中,WB-TG显示出显著的低凝血状态,与PPP-TG的发现形成鲜明对比.
- 需要进一步的研究来探索这些不同的TG评估的临床意义.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
01:24Disorders of Hemostasis
963
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
963
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:30Venous Thrombosis I: Introduction
11
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
11
01:09Coagulation
6.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.9K